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Expression of Ki67 was 11% when 1/3 of the cells were spared but 
augmented till 36% when only 10% were spared.
The viability ranged between 93-98% with the highest in the 1/10 sub-
cultivation group and the lowest in the 1/3 subcultivation group.
Conclusion: We could thus demonstrate a remarkable ability of this 
cell line to adapt to changing conditions. A decrease in doubling time 
up to 50 % due to reducing number of cells in each cell culture dish at 
subcultivation was seen. This accelerated proliferation seems to mainly 
have been accomplished by recruiting a higher fraction of cells in pro-
liferation reﬂected by the increased Ki67 expression. 
An accelerated proliferation might be of importance clinically, for 
example considering the effect of fractionated irradiation in a radiosen-
sitive cell population.
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Background: Although rhein had been shown to induce apoptosis in 
several cancer cell lines, the action mechanism of rhein induced cell 
cycle arrest and apoptosis at the molecular level is not well known. 
Method: In this study, we use ﬂow cytometry analysis of DNA content 
for cell cycle and apoptosis from A-549 cells treated with different 
concentrations of rhein; Poly (ADP ribose) monoclonal antibody assay 
for apoptosis in A-549 cells after treated with rhein; inhibition of rhein-
induced apoptosis by the caspase-3 inhibitor Ac-DEVD-CHO in A-549 
cells etc. We investigated the mechanisms of rhein on a human lung 
cancer A-549 cell that induce G0/G1 phase arrest and ROS and Ca2+ 
productions that play an important role for apoptosis which are char-
acterized by caspase activation and mitochondria dependent pathway. 
Rhein induced G0/G1 arrest through inhibition of cyclin D3, Cdk4, 
Cdk4, and Cyclin E. 
Result: The efﬁcacious induction of apoptosis was observed at 50 μM 
for 12 h and up to 72 h examinations which were examined by ﬂow 
cytometric method. Flow cytometric analysis demonstrated that rhein 
induced the loss of mitochondrial membrane potential (Δ m), cyto-
chrome c release from mitochondrion, promoted capases-9 activation 
then promoted the activation of caspase-3 and led to apoptosis. Rhein 
also increased the levels of Gadd153, p53, p21, Bax and cytochrome 
c but decreased the levels of Bcl-2. The Ca2+ chelator BAPTA was 
added to the cells before rhein was added to the cells, and it blocked the 
Ca2+ production and also inhibited rhein-induced apoptosis in A-549 
cells. 
Conclusions: Our data demonstrated that rhein induces apoptosis in 
A-549 cells via a Ca2+-dependent mitochondrial death pathway. 
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Lung cancer is characterized by abnormal cell growth, invasion, 
and angiogenesis. The actin cytoskeleton plays a major role in these 
processes. In lung cancer tissues, but not other tumors, we have found 
that paxillin can be overexpressed, ampliﬁed, or mutated. In vivo 
properties of mutant paxillin (A127T) and wild type paxillin-express-
ing cells in nude mice were determined utilizing H522 NSCLC cell 
line in a mouse xenograft model.H522 has no signiﬁcant expression 
of paxillin,therefore the properties of paxillin-transfected cells could 
be studied. Tumor growth in the A127T mutant paxillin markedly 
exceeded (P = 0.0019) that in the control vector or wild-type paxillin. 
H522 cells grew in nude mice as a solid mass without any invasion or 
angiogenesis, whereas both wild-type paxillin and the A127T paxillin 
mutant expressing H522 cells grew as nodular tumors. In addition to 
nodularity, A127T paxillin expressing H522 xenograft tumors were 
highly invasive into the adjacent muscle tissue. Upon gross examina-
tion, the A127T paxillin tumors had larger nodules as compared to the 
wild-type paxillin tumors. Tumor sections from mice in various groups 
were examined using antibodies speciﬁc for nuclear antigen Ki-67 (a 
marker for active cell division), CD31 (measuring microvessel density, 
MVD) and VEGF (vascular endothelial growth factor). There was 
enhanced cell proliferation, increased stroma, increased MVD and in-
creased VEGF expression in wild type paxillin H522 xenografts. In the 
A127T paxillin H522 xenografts, as compared to paxillin negative or 
wild-type paxillin positive cells, there was enhanced cell proliferation 
with decreased stroma formation, MVD, and VEGF. There was a strong 
correlation between paxillin expression and angiogenesis (p=0.01). In 
conclusion, results from this study establish an important role for paxil-
lin in lung cancer.
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Non-small cell lung cancer (NSCLC) is a difﬁcult disease to treat. 
Even with the best therapies and the recent advent of novel molecularly 
targeted therapies, the overall survival for all NSCLC patients is only 
20% over a ﬁve year period. c-Met receptor tyrosine kinases (RTKs) 
have been shown to be important in a variety of malignancies. We 
have examined the expression and gene ampliﬁcation of c-Met recep-
tor in various NSCLC cell lines using standard immunoblotting and 
FISH analysis respectively. It was found that there was overexpression 
of c-Met in most of the NSCLC cell lines (~75%), including H441, 
SKLU-1, H1993, A549, H1838, H358 and SW1573 except H-522 and 
H661. This was also evident in the lung tumor tissue immunoblotting 
and parafﬁn embedded lung cancer tissue micro array. FISH analysis 
revealed ampliﬁcation of the c-Met region on chromosome 7p11.2 to 
copy number 15 in 22% (two out of nine) of NSCLC cell lines, and 
correlated with high expression. Constitutively activated c-Met was 
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found in the ampliﬁed cell lines. This ampliﬁcation confers sensitiv-
ity of NSCLC to inhibitors of the tyrosine kinase activity of c-Met. To 
further determine the molecular characteristics of cell lines carrying 
c-Met ampliﬁcation, we investigated the levels of downstream effectors 
of c-Met, such as phospho paxillin, phospho-extracellular signal-
regulated kinase and phospho-S6 proteins. Interestingly, S6 kinase a 
serine-threonine kinase whose activation is thought to regulate a wide 
array of cellular processes involved in the mitogenic response including 
protein synthesis, translation of speciﬁc mRNA species, and cell cycle 
progression from G1 to S phase was more frequently activated in cell 
lines with gene ampliﬁcation of c-Met than in their wild-type counter-
parts. c- Met ampliﬁcation may thus identify a subset of lung cancers 
that are uniquely altered signaling which potentially sensitive to c-Met 
inhibition.
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Background: Lung cancer still remains one of the leading causes of 
all cancer related deaths. They can be divided into two major types, 
non small cell (NSCLC) and small cell (SCLC) lung cancers. Amongst 
the two, prognosis in patients with NSCLC is better compared to those 
with SCLC, however the overall survival rate is still very low (17%). 
A plethora of molecular changes due to various genomic alterations are 
known to contribute to the development and spread of lung cancers, for 
instance mutations in p53, RB, Ras, several receptor and non-receptor 
tyrosine kinases are known to contribute to the variety of phenotypes 
seen in lung cancer. One of the long term goals of our lab is to map and 
study the biological signiﬁcance of loss and gain of function mutations 
in various signaling molecules in lung cancer; with the idea of develop-
ing novel therapeutics. In this regard, we examined the role of Pax 
transcription factors in lung cancer. To date, the Pax family consists 
of nine members that are all characterized by the presence of a paired 
domain. They are indispensable for various developmental processes 
and several of them are known to play a signiﬁcant role in the develop-
ment of various cancers. In this initial study, we used a panel of both 
NSCLC and SCLC cell lines to determine the relative levels of various 
Pax proteins. 
Methods: Whole cell lysates from a panel of NSCLC and SCLC cell 
lines were prepared using RIPA Buffer. Equivalent amount cell lysates 
proteins were separated by SDS-PAGE and subjected to immunoblot-
ting using various commercially available anti-Pax antibodies. 
Speciﬁc Pax knockdown cells were also generated by transfecting com-
mercially available siRNA. The loss of the particular Pax expression 
was determined using immunoblotting procedures.
Results: We detected signiﬁcant expression of Pax8 in NSCLC and 
Pax5 in SCLC cell lines. In addition we could detect BCL2 but not 
BCL-XL, especially in the SCLC cell lysates. Since Pax3 is a known 
direct transcriptional activator of c-Met, a receptor tyrosine kinase that 
is known to play a signiﬁcant role in cancer metastasis, we therefore 
determined the protein expression levels of c-Met in the above cell 
lines. In general, in most of the cell lines where Pax expression was de-
tected, we also detected comparable levels of c-MET. We are currently 
determining how the Pax factors can regulate biological and biochemi-
cal processes in lung cancer.
Conclusions: Differential expression of Pax8 in NSCLC and Pax5 in 
SCLC can be further tested as biomarkers to characterize lung tumor 
tissue biopsies. This differential expression can be combined with other 
biomarkers to help distinguish between SCLC, NSCLC, and other 
tumors.
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Propose: Authors are to investigate DNA repair mechanisms 
involved in DNA damage induced by cis-Diammineplatinum 
dichloride(cisplatin), which is widely used for treatment of NSCLC. 
We also studied relevance of IGF-1 system in DNA repair mechanisms.
Methods: The effect on non-small cell lung cancer (NSCLC) cell 
line NCI-H1299 and NCI-H460 proliferation by IGF-1 and cisplatin 
treatment was measured by MTT assay. Changes of molecular system 
consisting HRR and NEJH were evaluated by immunoblotting and im-
munocytochemistry. Comet assay was applied to analyze inﬂuence of 
IGF-1 on DNA damage repair.
Results: 
1. Cisplatin treatment resulted in inhibition of cell proliferation in a 
dose dependent manner. IC50 and IC80 are about 33.3 uM and 9.1 
uM in H1299 and 33.7uM and 8uM in H460 cells. 50 ng/ml IGF-1 
treatment on each cells recovered about 20% of cell proliferation 
repressed by cisplatin.
2. Immunocytochemical study showed cisplatin treatment induced 
activation of gamma H2AX, and addition of 50 ng/mL IGF-1 po-
tentated its activation. Nuclear translocation of ATM and IRS-1 was 
promoted by cisplatin treatment, but was suppressed by IGF-1. On 
the other hand, translocation of ATR was enhanced by cisplatin and 
facilitated by IGF-1 treatment. 
3. Phsphorylation of ATM induced by cisplatin was conﬁrmed by 
immunoblotting, but not with IGF-1. Whereas IGF-1 induced ATR 
activation, and promoted gamma H2AX formation.
4. Reduced cisplatin induced DNA damage could verify IGF-1 effect 
with comet assay.
Conclusions: Activation of ATR pathway by IGF-1 might be primary 
recovery mechanism of cisplatin induced DNA damage.
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